Abide Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 45

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $268M

Abide Therapeutics General Information

Description

Oparator of a biopharmaceutical company intended to develop drugs for serious diseases with a significant unmet medical need. The company's platform allows users to efficiently identify, develop and validate small-molecule inhibitors that target serine hydrolases, a highly relevant but under-explored class of enzymes, enabling medical practitioners to simultaneously discover and understand the roles these enzymes play in human disease and identify selective inhibitors from a tailored chemical library.

Contact Information

Website
www.abidetx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 10835 Road to the Cure
  • Suite 250
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
H. Lundbeck
Vertical(s)
Life Sciences
Corporate Office
  • 10835 Road to the Cure
  • Suite 250
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abide Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 29-May-2019 $268M Completed Generating Revenue
5. Later Stage VC (Series A) 29-Jul-2016 Completed Startup
4. Seed Round Completed Startup
3. Early Stage VC 02-Mar-2014 Completed Startup
2. Grant 16-Jul-2013 $2.2M Completed Startup
1. Early Stage VC 17-Nov-2011 $2.2M $2.2M Completed Startup
To view Abide Therapeutics’s complete valuation and funding history, request access »

Abide Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Oparator of a biopharmaceutical company intended to develop drugs for serious diseases with a significant unmet medical
Drug Discovery
San Diego, CA
45 As of 2019

San Diego, CA
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abide Therapeutics Competitors (115)

One of Abide Therapeutics’s 115 competitors is BioTheryx, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioTheryx Venture Capital-Backed San Diego, CA
etherna Formerly VC-backed Niel, Belgium
Genevant Corporate Backed or Acquired Vancouver, Canada
Vividion Therapeutics Formerly VC-backed San Diego, CA
PEP-Therapy Venture Capital-Backed Evry Cedex, France
You’re viewing 5 of 115 competitors. Get the full list »

Abide Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abide Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cardinal Partners Venture Capital Minority
Celgene Corporation Minority
Angel (individual)
To view Abide Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Abide Therapeutics FAQs

  • When was Abide Therapeutics founded?

    Abide Therapeutics was founded in 2011.

  • Where is Abide Therapeutics headquartered?

    Abide Therapeutics is headquartered in San Diego, CA.

  • What is the size of Abide Therapeutics?

    Abide Therapeutics has 45 total employees.

  • What industry is Abide Therapeutics in?

    Abide Therapeutics’s primary industry is Drug Discovery.

  • Is Abide Therapeutics a private or public company?

    Abide Therapeutics is a Private company.

  • What is the current valuation of Abide Therapeutics?

    The current valuation of Abide Therapeutics is .

  • What is Abide Therapeutics’s current revenue?

    The current revenue for Abide Therapeutics is .

  • How much funding has Abide Therapeutics raised over time?

    Abide Therapeutics has raised $8.8M.

  • Who are Abide Therapeutics’s investors?

    Cardinal Partners, Celgene, and have invested in Abide Therapeutics.

  • Who are Abide Therapeutics’s competitors?

    BioTheryx, etherna, Genevant, Vividion Therapeutics, and PEP-Therapy are some of the 115 competitors of Abide Therapeutics.

  • When was Abide Therapeutics acquired?

    Abide Therapeutics was acquired on 29-May-2019.

  • Who acquired Abide Therapeutics?

    Abide Therapeutics was acquired by H. Lundbeck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process